World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
25706
World Ranking
17464
National Ranking
657

David M. Burger publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David M. Burger sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 652 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David M. Burger D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David M. Burger sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David M. Burger is affiliated with Radboud University in the Netherlands. Their research primarily focuses on medicine, with a strong emphasis on infectious diseases, epidemiology, pediatrics, perinatology, child health, virology, and pharmacology.

The scientist's work is concentrated on HIV/AIDS drug development and treatment, HIV/AIDS research and interventions, and HIV research and treatment. Additional areas of interest include Pneumocystis jirovecii pneumonia detection and treatment, pharmacological effects and toxicity studies, HIV-related health complications and treatments, and antibiotics pharmacokinetics and efficacy.

Recent papers by David M. Burger include:

  • Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications, 2022, Clinical Pharmacology & Therapeutics
  • Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial, 2020, The Lancet HIV
  • Drug-induced Liver Injury in a Patient With Coronavirus Disease 2019: Potential Interaction of Remdesivir With P-Glycoprotein Inhibitors, 2020, Clinical Infectious Diseases
  • 72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study, 2022, The Lancet HIV
  • Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial, 2020, The Lancet HIV

Frequent co-authors include:

  • Angela Colbers (44 publications)
  • Rob ter Heine (28 publications)
  • Diana M. Gibb (22 publications)
  • Tom Jacobs (16 publications)
  • Anna Turkova (15 publications)

David M. Burger has published extensively in the following venues:

  • Clinical Infectious Diseases (12 publications)
  • Clinical Pharmacokinetics (12 publications)
  • AIDS (11 publications)
  • British Journal of Clinical Pharmacology (10 publications)
  • Journal of Antimicrobial Chemotherapy (8 publications)

Best Publications

  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy

  • Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway.

    K. Brinkman;H.J.M. ter Hofstede;D.M. Burger;J.A.M. Smeitink

  • Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents

    Roger J. M. Bruggemann;Jan-Willem C. Alffenaar;Nicole M. A. Blijlevens;Eliane M. Billaud

  • Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

    Pythia T. Nieuwkerk;Mirjam A. G. Sprangers;David M. Burger;Richard M. W. Hoetelmans

  • A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis

    M.J. Boeree;A.H. Diacon;R. Dawson;K. Narunsky

  • Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy.

    Albert Tuldra;Carmina R. Fumaz;Ma José Ferrer;Ramon Bayes

  • Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: The effect of gender, race, and CYP2B6 polymorphism

    David Burger;Ilse van der Heiden;Charles la Porte;Marchina van der Ende

  • Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs

    van Robert Leeuwen;van Robert Leeuwen;D. H. S. Brundel;C. Neef;T. van Gelder

  • Antiretroviral drugs and the central nervous system

    Roelien H. Enting;Richard M.w. Hoetelmans;Joep M.a. Lange;David M. Burger

  • Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients.

    J P Dieleman;I C Gyssens;M E van der Ende;S de Marie

  • Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers.

    C.J.L. la Porte;E.P.H. Colbers;R.J. Bertz;D.S. Voncken

  • Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapy.

    David M Burger;Richard Mw Hoetelmans;Patricia Wh Hugen;Jan W Mulder

  • Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals.

    David Burger;Patricia W. Hugen;Peter Reiss;Inge Gyssens

  • Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs?

    Rob E Aarnoutse;Jonathan M Schapiro;Charles A B Boucher;Yechiel A Hekster

  • Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence.

    Carmina R. Fumaz;Jose A. Munoz-Moreno;José Molto;Eugènia Negredo

  • Updated guideline to perform therapeutic drug monitoring for antiretroviral agents.

    C.J.L. la Porte;D. Back;T. Blaschke;C.A.B. Boucher

  • Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi.

    Joep J. van Oosterhout;Neena Bodasing;Johnstone J. Kumwenda;Cooper Nyirenda

  • Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring.

    Patricia W. H. Hugen;Nienke Langebeek;David M Burger;Bert Zomer

  • Rifampicin Reduces Plasma Concentrations of Moxifloxacin in Patients with Tuberculosis

    H. M. J. Nijland;R. Ruslami;A. Juwono Suroto;D. M. Burger

  • Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials

    Victor Johan Bernard Huiskes;David Marinus Burger;Cornelia Helena Maria van den Ende;Bartholomeus Johannes Fredericus van den Bemt;Bartholomeus Johannes Fredericus van den Bemt

Frequent Co-Authors

Roger J. M. Brüggemann
Roger J. M. Brüggemann Radboud University
Kiat Ruxrungtham
Kiat Ruxrungtham Chulalongkorn University
Diana M. Gibb
Diana M. Gibb University College London
Joost P. H. Drenth
Joost P. H. Drenth Radboud University
Jos H. Beijnen
Jos H. Beijnen Utrecht University
Peter Reiss
Peter Reiss University of Amsterdam
Joep M. A. Lange
Joep M. A. Lange University of Amsterdam
Saye Khoo
Saye Khoo University of Liverpool
Jintanat Ananworanich
Jintanat Ananworanich Moderna Therapeutics (United States)
David Back
David Back University of Liverpool

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Online education is transforming how students prepare for rewarding healthcare careers. With flexible scheduling and accelerated options, many aspiring professionals are considering online programs as an alternative or complement to traditional medical school.

Advanced practice nursing is one of the fastest-growing fields. For those already holding a nursing license, programs such as the easiest dnp program reddit forums discuss the top online Doctor of Nursing Practice (DNP) programs known for flexibility and student support. If you’re starting your nursing journey, a 6 month lpn program online could help you qualify as a Licensed Practical Nurse (LPN) quickly and affordably.

Mental health also offers focused pathways. The shortest pmhnp program can train you to become a Psychiatric Mental Health Nurse Practitioner (PMHNP) in significantly less time than traditional on-campus options.

Interested in leadership or administration? Explore the cheapest online healthcare administration degree programs to gain management and policy skills essential for executive roles in hospitals or clinics.

These diverse online pathways make it possible to build a competitive healthcare career even if you choose not to attend medical school in the USA.

Best Scientists Citing David M. Burger

Trending Scientists

Recently Published Articles